Kenvue Shares Drop 2.1% While Deal Calculations Account for 88% of Decline in Tylenol Maker

Kenvue Inc. dropped 2.14% to $18.79 on Monday. Increased online searches for acetaminophen brought renewed attention to its Tylenol brand early Tuesday. However, the main factor behind the stock’s decline was its merger formula.

1 2 3